EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Anthelmintic Target Identification

Harrison T Shanley iD, Tao Wang iD, Aya C Taki iD, Joseph J Byrne, Bill C H Chang iD, Brad E Sleebs iD, Robin B Gasser iD

International Journal of Molecular Sciences · 15.04.2025 · 26 (8) · 3738

DOI: 10.3390/ijms26083738 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.04.2025. Verfasst von Harrison T Shanley und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Biosciences, Melbourne Veterinary School, Faculty of Science, The University of Melbourne, Parkville, VIC 3010, Australia. Hauptthemen laut MEDLINE: Anthelmintics. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council, PhylumTECH, Oz Omics Pty Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parasitic nematodes pose a significant threat to human and animal health, causing widespread morbidity and substantial socioeconomic losses globally. Despite the utility of anthelmintic drugs in parasite control, the emergence of widespread resistance necessitates the discovery of novel interventions. Advances through the use of whole-organism phenotypic screening have identified some promising nematocidal compounds, including nemacol, tolfenpyrad, UMW-9729, and ABX464. This article summarises efforts in this discovery, with a focus on Haemonchus contortus and Caenorhabditis elegans as model nematodes, and discusses approaches used for drug target deconvolution, including proteomic, chemical and genetic/genomic techniques. Stability-based proteomic assays, such as thermal proteome profiling, have been useful for identifying protein targets for these compounds, shedding light on their mechanisms of action. However, challenges remain in extrapolating findings from C. elegans to parasitic nematodes, emphasising the need for validation studies. Understanding drug–target interactions in nematodes is critical for developing next-generation anthelmintics and for mitigating the growing resistance challenge. This review outlines recent progress in this area and discusses future directions in target validation and anthelmintic development to support parasite control programmes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnthelminticsAnimalsCaenorhabditis elegansHaemonchusProteomicsHumansDrug DiscoveryDrug ResistanceNematoda

Stichwörter der Autor:innen

Caenorhabditis elegansHaemonchus contortusanthelmintic target identificationnematocide

Substanzen

Anthelmintics

Autor:innen und Institutionen

  • Department of Veterinary Biosciences, Melbourne Veterinary School, Faculty of Science, The University of Melbourne, Parkville, VIC 3010, Australia.
  • Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.

ORCID-Profile: Harrison T Shanley, Tao Wang, Aya C Taki, Bill C H Chang, Brad E Sleebs, Robin B Gasser

Förderung

  • Australian Research Council
  • PhylumTECH
  • Oz Omics Pty Ltd.

Zitieren

APA

Shanley, H. T., Wang, T., Taki, A. C., Byrne, J. J., Chang, B. C. H., Sleebs, B. E., & Gasser, R. B. (2025). Advances in Anthelmintic Target Identification. International Journal of Molecular Sciences, 26(8), 3738. https://doi.org/10.3390/ijms26083738

Vancouver

Shanley HT, Wang T, Taki AC, Byrne JJ, Chang BCH, Sleebs BE, et al. Advances in Anthelmintic Target Identification. International Journal of Molecular Sciences. 2025;26(8):3738. doi:10.3390/ijms26083738

BibTeX
@article{Shanley2025,
  author = {Shanley, Harrison T and Wang, Tao and Taki, Aya C and Byrne, Joseph J and Chang, Bill C H and Sleebs, Brad E and Gasser, Robin B},
  title = {Advances in Anthelmintic Target Identification},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {8},
  pages = {3738},
  doi = {10.3390/ijms26083738}
}
Kostenlos starten →